This grant funds research on drug use behaviors, prevention, and health services by analyzing existing social science, behavioral, and neuroimaging data.
Funder: National Institutes of Health
Due Dates: December 3, 2026 (Applications) | July 15, 2027 (Applications) | December 3, 2027 (Applications)
Funding Amounts: Up to $275,000 in direct costs over 2 years, with no more than $200,000 in any year
Summary: Supports innovative analysis of existing data to advance substance use, disorder, prevention, treatment, services, and HIV research.
Key Information: Primary data collection and clinical trials are not allowed.
The National Institute on Drug Abuse (NIDA), part of NIH, supports exploratory and developmental research using existing social science, behavioral, administrative, and neuroimaging data. This R21 opportunity covers alcohol, tobacco, prescription substances, and other substances, including their use trajectories, related disorders, morbidity and mortality, prevention, treatment, and health service utilization. It also supports research on substance use and HIV pathogenesis, prevention, care, and treatment.
The program seeks to make fuller use of public-use and other existing community-based or clinical datasets. NIDA particularly encourages Adolescent Brain Cognitive Development (ABCD) Study analyses, harmonized datasets, innovative computational methods, artificial intelligence, and integration of quantitative and qualitative data. Projects should identify tangible pathways to prevention interventions, services, policy, or other real-world impact wherever possible.